Regeneron shares fall after FDA rejects high-dose eye disease treatment

Regeneron said the rejection was "solely due to an ongoing review of inspection findings at a third-party filler."

...

Trump co-defendant Walt Nauta can't find local lawyer, has arraignment postponed

4 weeks ago

Ukraine war live updates: Countdown started on Kremlin regime, Ukraine official says; at least 13 dead in two missile strikes on Ukraine

4 weeks ago

Google is having productive talks with the EU on A.I. regulation, cloud boss says

4 weeks ago

Mortgage demand grows, driven by sales of new homes

4 weeks ago

Fanatics increases its offer to $225 million to acquire PointsBet's U.S. assets

4 weeks ago